A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease

Clinical Trial Site, Montreal, Canada

Clinical Trial Site, Ottawa, Canada

Clinical Trial Site, Toronto, Canada

Clinical Trial Site, Toronto, Canada

Clinical Trial Site, 's-Hertogenbosch, Netherlands

Clinical Trial Site, Amsterdam, Netherlands

Clinical Trial Site, Barcelona, Spain

Clinical Trial Site, Madrid, Spain

Clinical Trial Site, Sant Cugat del Vallès, Spain

Clinical Trial Site, Glasgow, United Kingdom

Clinical Trial Site, London, United Kingdom

Clinical Trial Site, Sheffield, United Kingdom

Clinical Trial Site, Southampton, United Kingdom